Blueprint Medicines Corporation (BPMC) financial statements (2021 and earlier)

Company profile

Business Address 45 SIDNEY STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1,550548494673268163
Cash and cash equivalents6851146840052163
Short-term investments187370426273162 
Other undisclosed cash, cash equivalents, and short-term investments67864(0)054 
Restricted cash and investments  0  0
Receivables71    
Inventory, net of allowances, customer advances and progress billings9     
Inventory9     
Other undisclosed current assets(638)(32)612(48)8
Total current assets:928517500686220170
Noncurrent Assets
Operating lease, right-of-use asset6873
Property, plant and equipment3438302467
Long-term investments and receivables67864  54 
Long-term investments67864  54 
Restricted cash and investments555511
Other noncurrent assets6106111
Total noncurrent assets:7911914030628
TOTAL ASSETS:1,718708540716283179
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities110935534149
Accounts payable453422
Accrued liabilities106895231126
Deferred revenue136
Debt 7 233
Deferred compensation liability     0
Deferred revenue and credits5116
Contract with customer, liability4
Other undisclosed current liabilities8 2211
Total current liabilities:13110660432919
Noncurrent Liabilities
Long-term debt and lease obligation8289  24
Long-term debt, excluding current maturities    24
Operating lease, liability8289
Liabilities, other than long-term debt36484834379
Deferred revenue and credits34379
Deferred revenue2940
Contract with customer, liability43
Deferred compensation liability, classified     0
Deferred rent credit  5
Other liabilities780000
Other undisclosed noncurrent liabilities  13   
Total noncurrent liabilities:11813761343813
Total liabilities:248243121776732
Stockholders' equity
Stockholders' equity attributable to parent1,470464419624213144
Common stock000000
Additional paid in capital2,1071,4121,017980421279
Accumulated other comprehensive loss(5)(3)(0)(0)(0) 
Accumulated deficit(631)(945)(598)(356)(207)(135)
Total stockholders' equity:1,470464419624213144
Other undisclosed liabilities and equity   1533
TOTAL LIABILITIES AND EQUITY:1,718708540716283179

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues7946745212811
Cost of revenue
(Cost of Goods and Services Sold)
(0)     
Gross profit:7936745212811
Operating expenses(485)(428)(292)(173)(100)(63)
Operating income (loss):309(361)(247)(151)(73)(52)
Nonoperating income (expense)6141030(1)
Other nonoperating income (expense)(0)(0)1031(0)
Interest and debt expense  (0)(0)(0)(1)
Income (loss) from continuing operations before income taxes:315(348)(237)(148)(73)(53)
Income tax expense(1)     
Income (loss) before gain (loss) on sale of properties:314(348)(237)(148)(73)(53)
Other undisclosed net income  00  
Net income (loss):314(348)(237)(148)(73)(53)
Other undisclosed net income attributable to parent    01
Net income (loss) attributable to parent:314(348)(237)(148)(72)(53)
Preferred stock dividends and other adjustments     (3)
Net income (loss) available to common stockholders, diluted:314(348)(237)(148)(72)(56)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):314(348)(237)(148)(73)(53)
Other comprehensive income 10   
Comprehensive income (loss):314(347)(237)(148)(73)(53)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)(3)(0)(0)0 
Comprehensive income (loss), net of tax, attributable to parent:311(350)(237)(148)(73)(53)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: